232 related articles for article (PubMed ID: 33932874)
1. Oncologic and survival outcomes for resectable locally-advanced HPV-related oropharyngeal cancer treated with transoral robotic surgery.
Yver CM; Shimunov D; Weinstein GS; Rajasekaran K; Cannady SB; Lukens JN; Lin A; Swisher-McClure S; Cohen RB; Aggarwal C; Bauml JM; Loevner LA; Newman JG; Chalian AA; Rassekh CH; Basu D; O'Malley BW; Brody RM
Oral Oncol; 2021 Jul; 118():105307. PubMed ID: 33932874
[TBL] [Abstract][Full Text] [Related]
2. Application of the Eighth Edition American Joint Committee on Cancer Staging System for HPV-Related Oropharyngeal Cancer Treated With Transoral Robotic Surgery.
Badhey AK; Olson A; Kadakia S; Russo J; Ting P; Khalid M; Yao M; Teng MS; Genden EM; Miles BA; Chai RL
Laryngoscope; 2018 May; 128(5):1133-1139. PubMed ID: 28990700
[TBL] [Abstract][Full Text] [Related]
3. Utility of up-front transoral robotic surgery in tailoring adjuvant therapy.
Gildener-Leapman N; Kim J; Abberbock S; Choby GW; Mandal R; Duvvuri U; Ferris RL; Kim S
Head Neck; 2016 Aug; 38(8):1201-7. PubMed ID: 27225507
[TBL] [Abstract][Full Text] [Related]
4. Locoregional Recurrence in p16-Positive Oropharyngeal Squamous Cell Carcinoma After TORS.
Carey RM; Brody RM; Shimunov D; Shinn JR; Mady LJ; Rajasekaran K; Cannady SB; Lin A; Lukens JN; Bauml JM; Cohen RB; Basu D; O'Malley BW; Weinstein GS; Newman JG
Laryngoscope; 2021 Dec; 131(12):E2865-E2873. PubMed ID: 34076275
[TBL] [Abstract][Full Text] [Related]
5. De-Escalated Adjuvant Therapy After Transoral Robotic Surgery for Human Papillomavirus-Related Oropharyngeal Carcinoma: The Sinai Robotic Surgery (SIRS) Trial.
Miles BA; Posner MR; Gupta V; Teng MS; Bakst RL; Yao M; Misiukiewicz KJ; Chai RL; Sharma S; Westra WH; Kim-Schulze S; Dayal B; Sobotka S; Sikora AG; Som PM; Genden EM
Oncologist; 2021 Jun; 26(6):504-513. PubMed ID: 33675133
[TBL] [Abstract][Full Text] [Related]
6. Outcomes in surgically resectable oropharynx cancer treated with transoral robotic surgery versus definitive chemoradiation.
Dhanireddy B; Burnett NP; Sanampudi S; Wooten CE; Slezak J; Shelton B; Shelton L; Shearer A; Arnold S; Kudrimoti M; Gal TJ
Am J Otolaryngol; 2019; 40(5):673-677. PubMed ID: 31201038
[TBL] [Abstract][Full Text] [Related]
7. The impact of transoral robotic surgery on the overall treatment of oropharyngeal cancer patients.
Smith RV; Schiff BA; Garg M; Haigentz M
Laryngoscope; 2015 Nov; 125 Suppl 10():S1-S15. PubMed ID: 26436491
[TBL] [Abstract][Full Text] [Related]
8. Oncological outcome following de-intensification of treatment for stage I and II HPV negative oropharyngeal cancers with transoral robotic surgery (TORS): A prospective trial.
Dabas S; Gupta K; Ranjan R; Sharma AK; Shukla H; Dinesh A
Oral Oncol; 2017 Jun; 69():80-83. PubMed ID: 28559025
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the impact of smoking on disease-specific survival outcomes in patients with human papillomavirus-associated oropharyngeal cancer treated with transoral robotic surgery.
Roden DF; Hobelmann K; Vimawala S; Richa T; Fundakowski CE; Goldman R; Luginbuhl A; Curry JM; Cognetti DM
Cancer; 2020 Jan; 126(9):1873-1887. PubMed ID: 32032441
[TBL] [Abstract][Full Text] [Related]
10. Risk of Pathologic Extranodal Extension and Other Adverse Features After Transoral Robotic Surgery in Patients With HPV-Positive Oropharynx Cancer.
Zebolsky AL; George E; Gulati A; Wai KC; Carpenter P; Van Zante A; Ha PK; Heaton CM; Ryan WR
JAMA Otolaryngol Head Neck Surg; 2021 Dec; 147(12):1080-1088. PubMed ID: 34673904
[TBL] [Abstract][Full Text] [Related]
11. Patterns of cervical node positivity, regional failure rates, and fistula rates for HPV+ oropharyngeal squamous cell carcinoma treated with transoral robotic surgery (TORS).
Cannon RB; Houlton JJ; Patel S; Raju S; Noble A; Futran ND; Parvathaneni U; Méndez E
Oral Oncol; 2018 Nov; 86():296-300. PubMed ID: 30409315
[TBL] [Abstract][Full Text] [Related]
12. Transoral robotic surgery with neck dissection versus nonsurgical treatment in stage I and II human papillomavirus-negative oropharyngeal cancer.
Bollig CA; Morris B; Stubbs VC
Head Neck; 2022 Jul; 44(7):1545-1553. PubMed ID: 35365915
[TBL] [Abstract][Full Text] [Related]
13. De-intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally invasive surgery for resectable HPV-positive oropharyngeal carcinoma.
Howard J; Dwivedi RC; Masterson L; Kothari P; Quon H; Holsinger FC
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012939. PubMed ID: 30550641
[TBL] [Abstract][Full Text] [Related]
14. Upfront transoral robotic surgery (TORS)
Zorzi SF; Agostini G; Chu F; Tagliabue M; Pietrobon G; Corrao G; Volpe S; Marvaso G; Colombo F; Cossu Rocca M; Gandini S; Gaeta A; Ruju F; Alterio D; Ansarin M
Acta Otorhinolaryngol Ital; 2022 Aug; 42(4):334-347. PubMed ID: 35938555
[TBL] [Abstract][Full Text] [Related]
15. Oncologic outcomes of transoral robotic surgery for HPV-negative oropharyngeal carcinomas.
Parhar HS; Weinstein GS; O'Malley BW; Shimunov D; Rassekh CH; Chalian AA; Newman JG; Basu D; Cannady SB; Rajasekaran K; Lin A; Lukens JN; Swisher-McClure S; Cohen RB; Bauml JM; Aggrawal C; Brody RM
Head Neck; 2021 Oct; 43(10):2923-2934. PubMed ID: 34101290
[TBL] [Abstract][Full Text] [Related]
16. Trends in Adjuvant Therapy After Surgery for Oropharyngeal Squamous Cell Carcinoma.
Philips R; Sagheer H; Barsouk A; Swendseid B; Johnson J; Bar Ad V; Luginbuhl A; Curry J; Cognetti D
Laryngoscope; 2022 Apr; 132(4):806-812. PubMed ID: 34553790
[TBL] [Abstract][Full Text] [Related]
17. Transoral robotic surgery for squamous cell carcinoma of the oropharynx in a primarily human papillomavirus-negative patient population.
Viros Porcuna D; Pollan Guisasola C; Viña Soria C; Cirauqui Cirauqui B; Pardo Muñoz L; Collurá F; Mesia Nin R
Clin Transl Oncol; 2020 Aug; 22(8):1303-1311. PubMed ID: 31858433
[TBL] [Abstract][Full Text] [Related]
18. Transoral Surgery in HPV-Positive Oropharyngeal Carcinoma: Oncologic Outcomes in the Veterans Affairs System.
Faraji F; Kumar A; Voora R; Soliman SI; Cherry D; Courtney PT; Finegersh A; Guo T; Cohen E; Califano JA; Mell L; Rose B; Orosco RK
Laryngoscope; 2024 Jan; 134(1):207-214. PubMed ID: 37255050
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
[TBL] [Abstract][Full Text] [Related]
20. Surgical Options for Locally Advanced Oropharyngeal Cancer.
Qureshi HA; Abouyared M; Barber B; Houlton JJ
Curr Treat Options Oncol; 2019 Apr; 20(5):36. PubMed ID: 30931485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
